Table 3 Evaluation of comorbidities and glycated hemoglobin according to digital retinography results, n = 108
Variables | No DR abnormalities (n = 104) n (%) | Retinopathy (n = 8) n (%) | p-value |
|---|---|---|---|
SAH | |||
No | 64 (61.5) | 1 (12.5) | 0.007q |
Yes | 40 (38.5) | 7 (87.5) | |
Dyslipidemia | |||
No | 59 (56.7) | 0 (0.0) | 0.002q |
Yes | 45 (43.3) | 8 (100.0) | |
Obesity | |||
No | 41 (39.4) | 0 (0.0) | 0.026q |
Yes | 63 (60.6) | 8 (100) | |
Smoker | |||
No | 82 (78.8) | 4 (50.0) | 0.063q |
Yes | 22 (21.2) | 4 (50.0) | |
Glycated hemoglobin | |||
Median | 5.8 (5.7–6.1) | 6.1 (6–6.1) | 0.031mw |
(P25–P75) | |||
Min–Max | 5.7–7.1 | 5.9–6.1 | |